Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Ribavirin for Crimean-Congo and Lassa Fever in DoD Facilities
NCT00992693Phase 2Withdrawn
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Sep 2009
- Primary completion
- Jul 2016
- Countries
- 1
01
Overview
A Phase 2 trial of ribavirin in Crimean–Congo hemorrhagic fever (CCHF), Lassa fever, sponsored by U.S. Army Medical Research and Development Command. Planned start Sep 2009; status: withdrawn.
02
Drugs
ribavirin
03
Conditions
Crimean–Congo hemorrhagic fever (CCHF)Lassa fever
Beyond the preview
Go deeper on NCT00992693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00992693.